Rita L. Yim

LKS Faculty Of Medicine, Hong Kong
Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Ropeginterferon alfa-2b for prefibrotic myelofibrosis and lower-risk myelofibrosis requiring cytoreduction.

Ropeginterferon alfa-2b for prefibrotic myelofibrosis and lower-risk myelofibrosis requiring cytoreduction.

Journal: Blood advances

Published: January 06, 2026

A clinico-genomic prognostic model for primary myelodysplastic neoplasm in Asia.

A clinico-genomic prognostic model for primary myelodysplastic neoplasm in Asia.

Journal: Blood cancer journal

Published: May 12, 2025

Implications of Clonal Hematopoiesis in Hematological and Non-Hematological Disorders.

Implications of Clonal Hematopoiesis in Hematological and Non-Hematological Disorders.

Journal: Cancers

Published: October 21, 2024

Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcome.

Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcome.

Journal: Blood advances

Published: October 04, 2024

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction.

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction.

Journal: Annals of hematology

Published: April 09, 2023

Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.

Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.

Journal: BMC cancer

Published: October 20, 2022

Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.

Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.

Journal: BMC cancer

Published: May 07, 2022

Epigenetic Silencing of PTEN and Epi-Transcriptional Silencing of MDM2 Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents.

Epigenetic Silencing of PTEN and Epi-Transcriptional Silencing of MDM2 Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents.

Journal: International journal of molecular sciences

Published: April 08, 2022

Single-Nucleotide Variations, Insertions/Deletions and Copy Number Variations in Myelodysplastic Syndrome during Disease Progression Revealed by a Single-Cell DNA Sequencing Platform.

Single-Nucleotide Variations, Insertions/Deletions and Copy Number Variations in Myelodysplastic Syndrome during Disease Progression Revealed by a Single-Cell DNA Sequencing Platform.

Journal: International journal of molecular sciences

Published: March 25, 2022

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome.

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome.

Journal: International journal of molecular sciences

Published: August 31, 2021

Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study.

Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study.

Journal: Blood advances

Published: March 19, 2021

Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting.

Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 23, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026